INBP supply chain intelligence for Integrated BioPharma, Inc.: verified suppliers, customers, debt relationships, acquisitions, and ownership data.
Data compiled by Redley Lamar · ChainSifter Intelligence
Integrated BioPharma, Inc. (INBP) is shown with relationship data already present in ChainSifter's database. Counts below come from stored supply-chain records and filing/source URLs where available; missing source URLs are not filled in or estimated.
| Ticker | Name | Confidence | Evidence |
|---|---|---|---|
| HERBALIFE | HERBALIFE | 92% | In each of the nine months ended March 31, 2026 and 2025, a significant portion of our consolidated net sales, approximately 90%, were concentrated among two customers in our Contract Manufacturing S… |
| LIFE-EXTENSION | LIFE-EXTENSION | 92% | In each of the nine months ended March 31, 2026 and 2025, a significant portion of our consolidated net sales, approximately 90%, were concentrated among two customers in our Contract Manufacturing S… |
| HOTPACK-GLOBAL-INC | HOTPACK-GLOBAL-INC | 90% | Two other customers, Thermosource Tooling and Manufacturing and Hotpack Global, Inc. (customers of our Other Nutraceutical Businesses Segment), while not significant customers of our consolidated net… |
| THERMOSOURCE-TOOLING-AND-MANUFACTURING | THERMOSOURCE-TOOLING-AND-MANUFACTURING | 90% | Two other customers, Thermosource Tooling and Manufacturing and Hotpack Global, Inc. (customers of our Other Nutraceutical Businesses Segment), while not significant customers of our consolidated net… |
| CHEM-INTERNATIONAL-INC | CHEM-INTERNATIONAL-INC | 62% | egments include: (a) Contract Manufacturing operated by Manhattan Drug Company, Inc. (“MDC”), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers an… |
| IHT-PROPERTIES-CORP | IHT-PROPERTIES-CORP | 62% | cing a slight negative impact on our margins due to inflation, delays in shipments and tightened labor markets. During the first quarter of calendar 2022, the war in Ukraine affected our customer’s b… |
| INTEGRATED-HEALTH-TECHNOLOGIES-INC | INTEGRATED-HEALTH-TECHNOLOGIES-INC | 62% | nutritional supplements and herbal products. The Company’s customers are located primarily in the United States and Luxembourg. The Company was originally incorporated in the state of Delaware on Aug… |
| MANHATTAN-DRUG-COMPANY-INC | MANHATTAN-DRUG-COMPANY-INC | 62% | egments include: (a) Contract Manufacturing operated by Manhattan Drug Company, Inc. (“MDC”), which manufactures vitamins and nutritional supplements for sale to distributors, multilevel marketers an… |
| OPERATIONS-INTEGRATED-BIOPHARMA-INC | OPERATIONS-INTEGRATED-BIOPHARMA-INC | 62% | ents. 5 INTEGRATED BIOPHARMA, INC. AND ITS SUBSIDIARIES NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS (in thousands, except share and per share amounts) (Unaudited) Note 1. Nature of Operation… |
| VITAMIN-REALTY-ASSOCIATES-LLC | VITAMIN-REALTY-ASSOCIATES-LLC | 62% | se issues first arose as result of the COVID- 19 pandemic and other geo-political events. During the first quarter of calendar 2022, the war in Ukraine affected the Company’s customer’s business oper… |
| Instrument | Description | Confidence | Evidence |
|---|---|---|---|
| INBP-DEBT | Debt stack $18,000 | 90% | Market cache reports total debt of $18,000. |
| INBP-DEBT-10270 | Xbrl Convertible | 90% | xbrl convertible detail from xbrl 2019-06-30. |